Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dutasteride and Tamsulosin in BPH
NCT00701779Phase 4Completed
- Start
- Sep 2005
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dutasteride in benign prostatic hyperplasia (BPH). Primary endpoints: International Prostate Symptom Score at 12 months, Peak Flow Rate at 12 months and 3 more. Started Sep 2005; status: completed.
02
Drugs
dutasteride
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00701779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00701779.